$143.450
-0.057 (-0.04%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AXSM Prediction & Forecast by Similar Chart Analysis
Alphio's AXSM stock price prediction model matches the current Axsome Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $143.56 (+0.08%). The 1-week path is $141.40 (-1.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Axsome Therapeutics, Inc. Stock?
Axsome Therapeutics Inc is currently not a strong buy due to its low RSI of 15.938, indicating oversold conditions, and a significant recent price drop of 7.70% over the last five days. However, the company's revenue growth is promising, with a 46% year-over-year increase to $218.4 million in Q2, driven by the strong performance of its drug Auvelity. The main risk is the widening net loss per share, which stands at -0.99, indicating ongoing financial challenges. Therefore, while there are positive growth indicators, the current technical and financial situation suggests holding rather than buying.
AXSM stock price ended at $143.45 on Thursday, after losing -0.04%
Axsome Therapeutics, Inc. (AXSM) last closed at $143.4499969, losing -0.04%. These facts feed the 1-day and 1-week AXSM price prediction above.
Analyst Consensus
Axsome Therapeutics, Inc. (AXSM): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Axsome Therapeutics, Inc. (AXSM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AXSM, ranked by similarity.
Seasonality analysis for AXSM
Historically the probability of a positive October return for AXSM is 71.64%. July offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AXSM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $183.47 | $198.72 | $241.76 | +38.53% |
| Nov 2026 | $155.82 | $198.72 | $211.41 | +38.53% |
| Dec 2026 | $131.38 | $153.74 | $200.39 | +7.17% |
In 2026, Axsome Therapeutics, Inc. (AXSM) is projected to range from $131.38 to $241.76.
Axsome Therapeutics, Inc. 2026 monthly forecast
In Oct 2026, Axsome Therapeutics, Inc. is projected to average $198.72, with a low of $183.47 and high of $241.76.
In Nov 2026, Axsome Therapeutics, Inc. is projected to average $198.72, with a low of $155.82 and high of $211.41.
In Dec 2026, Axsome Therapeutics, Inc. is projected to average $153.74, with a low of $131.38 and high of $200.39.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.